|
Market Closed -
Nasdaq
23:00:00 21/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.650 USD | -1.20% |
|
-1.20% | -75.37% |
| 11/09/25 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 01/04/25 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 5.39M 4.62M 4.32M 3.96M 7.43M 516M 7.52M 51.07M 19.92M 259M 20.25M 19.81M 857M | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61M 1.38M 1.29M 1.18M 2.22M 154M 2.25M 15.26M 5.95M 77.48M 6.05M 5.92M 256M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -1.20% | ||
| Current month | -75.37% | ||
| Current year | -75.37% |
| 5 years | 1.65 |  | 310.8 |
| 10 years | 1.65 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.3M -7.97M -7.46M -6.83M -12.81M -890M -12.98M -88.09M -34.35M -447M -34.93M -34.17M -1.48B | -7.02M -6.02M -5.63M -5.15M -9.67M -672M -9.8M -66.51M -25.94M -338M -26.37M -25.8M -1.12B |
| Net Debt | -7.34M -6.29M -5.88M -5.39M -10.11M -702M -10.24M -69.52M -27.11M -353M -27.56M -26.96M -1.17B | -3.78M -3.24M -3.03M -2.77M -5.21M -362M -5.27M -35.8M -13.96M -182M -14.2M -13.89M -601M |
Employees
-
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | $1.650 | -1.20% | 83,147 |
| 20/08/26 | $1.670 | -3.47% | 27,588 |
| 19/08/26 | $1.730 | +1.17% | 61,642 |
| 18/08/26 | $1.710 | -1.16% | 45,730 |
| 17/08/26 | $1.730 | +3.59% | 57,052 |
- Stock Market
- Stocks
- GRI Stock
Select your edition
All financial news and data tailored to specific country editions
